Jiangsu NHWA Pharmaceutical Co., Ltd.September 1, 2023

FDA 483 - Jiangsu NHWA Pharmaceutical Co., Ltd. - September 01, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Jiangsu NHWA Pharmaceutical Co., Ltd.

Record Details

An FDA inspection of Jiangsu NHWA Pharmaceutical Co., Ltd., an API manufacturer in Xuzhou, Jiangsu, China, revealed significant deficiencies in its quality system. The firm failed to adequately investigate customer complaints regarding foreign particles in APIs and did not properly qualify its contract testing laboratories. Additionally, raw materials and APIs were not stored under appropriate temperature and humidity conditions, leading to multiple excursions.

Company: Jiangsu NHWA Pharmaceutical Co., Ltd.
Inspection Date: September 1, 2023
Product Type: Drugs
Office: Center for Veterinary Medicine
People: Eileen A. Liu
Alan P Kuretsberg

Open in Dashboard

ID · 39f32da0-b7e1-490e-b123-aec0a446db2e